Recent developments include the reporting of full year fiscal 2025 financial results, announcement of a conference call for these results, and completion of the underwriters’ over-allotment option related to the company's initial public offering.

• Buda Juice reported full year fiscal 2025 financial results on March 26, 2026, highlighting net income of $3.53 million and basic EPS of $0.28 [N1].
• The company announced a conference call and webcast for the fourth quarter and full year fiscal 2025 financial results on March 12, 2026 [N2].
• Buda Juice announced the full exercise of underwriters’ over-allotment option in connection with its initial public offering on January 22, 2026 [N3].

Buda Juice has established a differentiated product category with UltraFresh™ juices that preserve authentic taste and nutrients through a proprietary cold chain. Its asset-light model and strategic grower relationships support scalable production and supply. The company’s geographic expansion plan through multiple regional hubs aims to increase market reach and consumer access. Its diversified product portfolio, including organic wellness shots and private label offerings, allows penetration into multiple market segments. Strong liquidity and recent successful IPO provide capital to support growth initiatives. The experienced leadership team and retail relationships enhance sales and distribution capabilities.

Buda Juice operates in a highly competitive beverage industry with larger, better-capitalized competitors that may replicate or surpass its product offerings and marketing efforts. The company’s reliance on a limited number of customers, with one accounting for the majority of sales, poses concentration risk. Maintaining the integrity of the cold chain over expanded geographies presents operational challenges and risks to product quality and brand reputation. Supply chain disruptions, particularly in sourcing fresh citrus, could impact production and margins. The company’s limited operating history outside Texas and surrounding states adds uncertainty to its growth prospects. Regulatory compliance and potential advertising claims also present risks.

Buda Juice's competitive advantages stem from its proprietary end-to-end cold chain infrastructure maintaining continuous 35°F temperature control, which requires significant capital and expertise. Its asset-light model balances quality control with operational flexibility. Long-term relationships with citrus growers provide consistent premium fruit supply, creating a barrier to entry. The executive team's established relationships with major U.S. grocery retailers facilitate market access. The company's turnkey retail model reduces operational complexity and costs for retailers, positioning Buda Juice as a category resource rather than a simple vendor. These factors collectively create significant barriers for competitors to replicate its UltraFresh™ juice category and distribution model.

• Customer Concentration Risk: One customer accounted for approximately 97% of net sales in 2025, creating significant revenue concentration risk. Loss or reduction of purchases by this customer could materially impact financial results.
• Competitive Pressure: The beverage industry includes large multinational and emerging companies with greater resources and established distribution, which may limit Buda Juice's market share growth and pricing power.
• Operational Complexity of Cold Chain: Maintaining continuous cold chain logistics is capital intensive and operationally challenging, especially as the company expands geographically, risking product quality and brand reputation if not executed consistently.
• Supply Chain and Agricultural Risks: Dependence on fresh citrus and other agricultural commodities exposes the company to seasonal variability, environmental conditions, tariffs, and supply disruptions that could affect availability, cost, and product quality.
• Brand and Quality Perception: The company’s success depends on consumer perception of freshness, safety, and quality. Any lapses in food safety, product consistency, or labeling could damage brand reputation and sales.

• Buda Juice, Inc. is a Delaware corporation that began trading on NYSE American under ticker BUDA on January 8, 2026.
• The company pioneered the UltraFresh™ juice category, delivering cold-crafted citrus-based juices, lemonades, and wellness shots through an end-to-end cold chain platform maintaining continuous 35°F temperature control from fruit to retail shelf.
• Products include organic wellness shots (2 oz), Buda Fresh value-forward non-organic citrus juices (lime, lemon, orange, grapefruit), citrus-based lemonades and limeades, and private label products in both organic and non-organic variants.
• The company operates an asset-light model with integrated production and outsourced logistics, leveraging long-term relationships with citrus growers and a SQF Level II certified high-tech production plant adhering to FDA safety protocols.
• Buda Juice's business strategy includes geographic expansion via a three-facility hub model: Dallas (serving 45 million consumers), Southeast hub in South Carolina (serving 75 million consumers, planned 2026), and Western hub in Arizona/Nevada (serving 60 million consumers, planned 2027).
• Sales and distribution leverage strategic relationships, a multi-channel approach including regional and national brokers, and direct retail access through experienced leadership.
• The company reported net income of $3.53 million and basic EPS of $0.28 for the fiscal year ended December 31, 2025, with a current ratio of 5.5 indicating strong liquidity as of that date.
• Buda Juice depends heavily on a limited number of customers, with one customer representing approximately 97% of net sales in 2025, though efforts to diversify are underway.
• The company faces competition from larger, better-capitalized beverage companies with established brands and distribution, including those expanding into fresh or cold-pressed juice categories.
• Risks include limited operating history outside Texas and surrounding states, dependence on cold chain logistics, supply chain challenges for fresh citrus, and the need to maintain brand reputation for freshness and quality.
• The company has no material litigation and complies with FDA and FTC regulations related to food safety and advertising.
• Buda Juice completed an initial public offering in January 2026, raising $20 million gross proceeds, with underwriters receiving warrants exercisable starting July 2026.
• The company employs 39 full-time employees as of December 31, 2025.